AIM: This study was aimed to investigate whether any association could be found between the presence of an inflamed and infected periodontium (e.g., gingivitis and periodontitis) and the development of bacteremia during neutropenia following allogeneic hematopoietic stem cell transplantation (HSCT). METHODS: Eighteen patients underwent a periodontal examination before HSCT. Patients were classified as periodontally healthy [all periodontal pocket depths (PPD) ≤ 4 mm and bleeding on probing (BOP) ≤ 10%) or as having gingivitis/periodontitis (PPD ≥ 4 mm and BOP > 10%]. Oral mucositis (OM) was scored using the daily mucositis score. Blood cultures were taken at least twice weekly. RESULTS: Five patients were periodontally healthy, while 13 patients had gingivitis or periodontitis. Twelve patients (67%) developed bacteremia during neutropenia, of which 11 patients (61%) had one or more episodes of bacteremia due to coagulase-negative staphylococci (CONS, most often Staphylococcus epidermidis) or to oral viridans streptococci (OVS), or both. Patients with gingivitis/periodontitis more often had bacteremia than those with a healthy periodontium (p = 0.047), and BOP was associated with bacteremia (p = 0.049). All patients developed ulcerative OM, but its severity and duration were not associated with bacteremia. OM duration and the length of stay in the hospital were strongly correlated (R = 0.835, p ≤ 0.001). CONCLUSION: This study indicates that periodontal infections may contribute to the risk of developing OVS and CONS bacteremia during neutropenia following HSCT. While our results point to the importance of periodontal evaluation and management before HSCT, further studies on periodontal contribution to systemic infectious complications are warranted.
AIM: This study was aimed to investigate whether any association could be found between the presence of an inflamed and infected periodontium (e.g., gingivitis and periodontitis) and the development of bacteremia during neutropenia following allogeneic hematopoietic stem cell transplantation (HSCT). METHODS: Eighteen patients underwent a periodontal examination before HSCT. Patients were classified as periodontally healthy [all periodontal pocket depths (PPD) ≤ 4 mm and bleeding on probing (BOP) ≤ 10%) or as having gingivitis/periodontitis (PPD ≥ 4 mm and BOP > 10%]. Oral mucositis (OM) was scored using the daily mucositis score. Blood cultures were taken at least twice weekly. RESULTS: Five patients were periodontally healthy, while 13 patients had gingivitis or periodontitis. Twelve patients (67%) developed bacteremia during neutropenia, of which 11 patients (61%) had one or more episodes of bacteremia due to coagulase-negative staphylococci (CONS, most often Staphylococcus epidermidis) or to oral viridans streptococci (OVS), or both. Patients with gingivitis/periodontitis more often had bacteremia than those with a healthy periodontium (p = 0.047), and BOP was associated with bacteremia (p = 0.049). All patients developed ulcerative OM, but its severity and duration were not associated with bacteremia. OM duration and the length of stay in the hospital were strongly correlated (R = 0.835, p ≤ 0.001). CONCLUSION: This study indicates that periodontal infections may contribute to the risk of developing OVS and CONS bacteremia during neutropenia following HSCT. While our results point to the importance of periodontal evaluation and management before HSCT, further studies on periodontal contribution to systemic infectious complications are warranted.
Authors: P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun Journal: Support Care Cancer Date: 2003-03-13 Impact factor: 3.603
Authors: Peter B Lockhart; Michael T Brennan; Martin Thornhill; Bryan S Michalowicz; Jenene Noll; Farah K Bahrani-Mougeot; Howell C Sasser Journal: J Am Dent Assoc Date: 2009-10 Impact factor: 3.634
Authors: J Radocha; P Paterová; A Zavřelová; B Víšek; F Gabalec; H Žemličková; P Žák Journal: Folia Microbiol (Praha) Date: 2017-08-03 Impact factor: 2.099
Authors: V Allareddy; S R Venugopalan; S V K Eswaran; S Rampa; S Anamali; R P Nalliah; K Shin; V Allareddy; S Elangovan Journal: Bone Marrow Transplant Date: 2015-01-19 Impact factor: 5.483
Authors: Juan Jose Toro; Francisca Cecilia Gushiken; Deanna Schneider; Shuko Lee; David Johannes Haile; Cesar Ovidio Freytes Journal: Support Care Cancer Date: 2016-03-17 Impact factor: 3.603
Authors: Victoria Hickey; Laura Flesch; Adam Lane; Ahna L H Pai; John Huber; Priscila Badia; Stella M Davies; Christopher E Dandoy Journal: Pediatr Blood Cancer Date: 2018-07-26 Impact factor: 3.167
Authors: Diana T Nguyen; Sepideh Shayani; Joycelynne Palmer; Andrew Dagis; Stephen J Forman; Joel Epstein; Ricardo Spielberger Journal: Support Care Cancer Date: 2015-03-21 Impact factor: 3.603
Authors: K Tsuji; Y Shibuya; M Akashi; S Furudoi; K Yakushijin; S Kawamoto; A Okamura; H Matsuoka; T Komori Journal: J Dent Res Date: 2014-12-10 Impact factor: 6.116
Authors: Heidi J Hansen; Cherry Estilo; Adepitan Owosho; Armand Karl Solano; Joseph Randazzo; Joseph Huryn; SaeHee K Yom Journal: Support Care Cancer Date: 2020-09-08 Impact factor: 3.603